LivaNova PLC revenue breakdown overview

LivaNova PLC revenue for the last year amounted to 1.15 B USD, the most of which — 588.98 M USD — came from its highest performing source at the moment, Cardiopulmonary, the year earlier bringing 500.31 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought LivaNova PLC 635.04 M USD, and the year before that — 571.56 M USD.